| Variable | Frequency (number or CI) | Percentage (%) or IQR |
| Median age | 36 | 30 - 44 |
| Age (years) |
|
|
| 18 - 30 | 72 | 21.2 |
| 30 - 40 | 146 | 42.9 |
| 41 - 50 | 78 | 22.9 |
| 51 - 60 | 35 | 10.3 |
| >60 | 9 | 2.7 |
| Gender |
|
|
| Male | 252 | 74.1 |
| Female | 88 | 25.9 |
| Residence |
|
|
| Mwanza city | 84 | 24.7 |
| Mwanza region | 38 | 11.2 |
| Outside Mwanza | 218 | 64.1 |
| Comorbidities |
|
|
| Diabetes | 8 | 2.4 |
| Hypertension | 3 | 0.9 |
| Anti-HCV positivity | 4 | 1.2 |
| Alanine transaminase > 2 × UNL (U/L) | 71 | 20.9 |
| Aspartate aminotransferase > 2 × UNL (U/L) | 85 | 25.0 |
| Total bilirubin > 5 × UNL (µmol/L) | 156 | 45.9 |
| Albumin (g/L) | 43.1 | 19.0 - 45.5 |
| Alfa fetoprotein (ng/mL) | 3.5 | 0.8 - 6.3 |
| Platelets (109/L) | 206 | 166 - 205 |
| Total white blood count (109/L) | 4.8 | 4.0 - 6.0 |
| Anemia | 56 | 16.5 |
| HBV viral load (IU/mL) |
|
|
| Undetectable (<20) | 34 | 10 |
| 20 - 2000 | 197 | 57.9 |
| 2001 - 20,000 | 67 | 19.7 |
| >20,000 | 42 | 12.4 |
| Liver cirrhosis | 51 | 15.0 |
| APRI score > 2 | 19 | 5.6 |
| Clinical diagnosis | 42 | 12.4 |
| Both criteria | 10 | 2.9 |
| Significant fibrosis | 18 | 5.3 |